Links2HealthierBubs: Influenza And Pertussis Vaccine Effectiveness And Safety In Pregnancy
Funder
National Health and Medical Research Council
Funding Amount
$676,333.00
Summary
Vaccination during pregnancy can offer protection against severe respiratory disease for infants in the first six months of life. For this reason, influenza and pertussis vaccines are routinely recommended during each pregnancy. Unfortunately, little is known about the ‘real world’ effect of both vaccines. We plan to conduct the largest and most comprehensive study to date to evaluate all vaccines routinely recommended in pregnancy in Australia.
The Natural History Of Unassisted Smoking Cessation In Australia
Funder
National Health and Medical Research Council
Funding Amount
$329,595.00
Summary
The majority of ex-smokers who successfully quit have done so without using pharmaceutical or counselling support. This study will produce pioneering insights into how and why so many smokers successfully quit without formal assistance. The findings will be conveyed to government, not-for-profit groups, and tobacco cessation professionals in order to help foster favourable social climates for smoking cessation and construct empowering messages about smoking cessation via self-change strategies.
Primary Prevention Of Infant Food Allergy: A Randomised Controlled Trial Of Postnatal Vitamin D Supplementation
Funder
National Health and Medical Research Council
Funding Amount
$1,723,793.00
Summary
Low vitamin D has been linked to a range of health conditions but, unlike many countries, Australia does not recommend supplementing infants with vitamin D. Good quality research on the effectiveness of vitamin D supplementation to prevent disease is lacking. Our trial of 2330 infants examines whether a daily dose of vitamin D prevents the development of food allergy. Vitamin D is safe and low cost. Infant supplementation may be the first simple strategy to reduce this common childhood condition
Effectiveness And Cost-Effectiveness Of HPV Vaccination And HPV-Based Cervical Cancer Screening Strategies In China
Funder
National Health and Medical Research Council
Funding Amount
$420,692.00
Summary
In the absence of preventative initiatives, up to 187,000 women will develop cervical cancer in China every year. However, the disease is preventable using human papillomavirus (HPV) vaccination and primary HPV screening. Building on previous work, we will evaluate the most effective and cost-effective options for cervical cancer prevention, in order to provide an comprehensive evidence base for China’s health decision-makers.